HCG for Weight Loss: What the Evidence Actually Says

Written by Empire Medical Training Editorial Team

Medically reviewed by Betsy Greenleaf, DO Board-Certified OB/GYN & Urogynecologist; Empire Director of Anti-Aging

Updated June 2026 ·12 min read

HCG for weight loss is a topic providers should understand precisely because patients ask about it — not because the evidence supports it. The honest clinical bottom line, stated up front, is this: HCG is not FDA-approved for weight loss, controlled studies have repeatedly failed to show it works beyond the extreme diet it accompanies, and the FDA has warned against over-the-counter HCG weight-loss products. A credible weight-management practice has to be able to explain that clearly, kindly, and accurately when a patient walks in asking for it.

This guide situates HCG within the broader field of medical weight loss and is written for clinicians who want an accurate, balanced overview. It is clinical education, not medical advice, and nothing here should be read as an endorsement, a treatment recommendation, or a protocol to follow.

What is HCG?

Human chorionic gonadotropin (HCG) is a glycoprotein hormone produced primarily by the placenta during pregnancy. It is the hormone home pregnancy tests detect, and it plays a central role in sustaining early pregnancy. Clinically, purified or recombinant HCG has legitimate, approved uses — for example in fertility medicine and in certain hypogonadism contexts — where it acts on luteinizing-hormone (LH) receptors to influence gonadal hormone production.

None of those approved indications is weight loss. The reason HCG appears in a weight-management discussion at all is historical and commercial, not pharmacologic: a single mid-century clinician proposed that the hormone could help the body shed fat, and the idea proved far more durable than the evidence behind it. Understanding HCG correctly starts with separating what the hormone genuinely does in the body from what a diet program has claimed it does.

The HCG diet: history and the Simeons protocol

The HCG diet dates to the 1950s, when British endocrinologist Dr. Albert T. W. Simeons introduced it. Working in India, Simeons reported that obese patients given HCG alongside a very-low-calorie diet seemed to lose fat rather than lean tissue, and he published his protocol in a book titled Pounds and Inches: A New Approach to Obesity.

The original Simeons protocol was severe. It combined daily HCG injections with a strict diet of only about 500 calories per day, structured in phases — a brief loading period, an extended phase of HCG plus the 500-calorie diet, and a maintenance phase in which calories were increased but starches and sugars were avoided. Over the decades since, the diet has been repackaged in many forms, including HCG drops, sprays, and pellets, along with assorted tweaks to the calorie ceiling and duration. The branding has changed; the central, unproven premise has not.

How HCG is claimed to work

Simeons theorized that HCG, a hormone of pregnancy, could mobilize stored fat, suppress appetite, and redistribute fat from problem areas — sparing lean muscle while a patient ate almost nothing. Proponents have layered additional claims on top over the years: that HCG acts as a hypothalamic appetite suppressant, that it promotes leptin gene expression, that by stimulating LH receptors and raising testosterone it enhances lipolysis from abnormal fat stores under conditions of severe calorie restriction.

The marketing language built on those claims is appealing and specific: patients are told they will lose one to two pounds per day with little or no hunger, that exercise is unnecessary, and that HCG is a “natural” protein hormone. It is precisely because these claims are so concrete and attractive that providers need to be able to address them directly. The problem is not that the claims are vague — it is that they have not survived testing.

What the evidence actually shows

This is the section that matters most. Numerous studies over many years have failed to show that HCG is effective for weight loss, or that it reduces the hunger and discomfort associated with a very-low-calorie diet. The fat-mobilization hypothesis that underpins the whole protocol has not been borne out; even animal work, such as rat studies examining HCG's purported effect on lipolysis, has been unable to confirm it.

The cleanest way to understand the result is through the design of the controlled trials. When patients are placed on the same extreme low-calorie diet and then randomized to receive HCG or placebo, both groups lose a comparable amount of weight. In other words, the weight loss tracks the diet, not the hormone. Whatever the scale shows on an HCG program is the predictable consequence of eating roughly 500 calories a day — a person will lose weight on that intake whether or not an injection accompanies it.

It is worth being candid about the quality of the literature, because proponents often cite a handful of supportive-sounding reports. The studies that appear to favor HCG tend to be few, older, and limited by small participant numbers and methodological weakness, while the better-controlled trials consistently find no benefit. The honest reading of the full body of evidence is not “mixed” in any meaningful clinical sense — it is that the weight effect attributed to HCG is, on examination, the placebo effect plus a starvation diet. Part of the diet's perceived strength has always been the absolute control of intake and the psychological “win” of rapid early loss, both of which can occur with or without the hormone.

Safety and regulatory status

Two distinct safety questions matter here, and conflating them does patients a disservice. The first is the regulatory status of HCG products. HCG is not FDA-approved for weight loss, and the FDA has specifically warned against over-the-counter HCG weight-loss products — the homeopathic drops, sprays, and pellets sold online and in stores. Those products are considered unproven and illegal for weight-loss claims; no nonprescription HCG product is recognized as safe and effective for shedding weight. HCG is also on the World Anti-Doping Agency's prohibited list, a relevant detail for athletes.

The second, and arguably larger, safety issue is the diet the protocol requires. The real hazard of the HCG program is the 500-calorie regimen riding alongside it. Very-low-calorie diets in this range are no more effective for durable weight loss than a more moderate 1,200–1,500-calorie plan, and they are widely regarded as unsafe and unnecessary. The documented downsides of such extreme restriction include electrolyte imbalances, gallstones and gallbladder problems, muscle loss, temporary hair loss, nutrient deficiencies, hypoglycemia, elevated cortisol and physiologic stress, constipation, gout, a higher risk of binge eating, and increased risk of depression — with the loss often unsustainable once normal eating resumes.

HCG itself is not without reported adverse effects either — irregular menses, migraine exacerbation, rare allergic reactions or edema, rare temporary hair loss, and concerns around thrombosis — and it carries meaningful contraindications. A history of cancer is a particularly important one, given hormonal signaling's role in the growth and progression of many cancers; other commonly cited cautions include congestive heart failure, hormone-sensitive conditions, and significant systemic illness. Specific dosing, dilution math, and the exact protocol mechanics are deliberately left to structured clinical training rather than a public reference page.

Why HCG is still discussed

If the evidence is this clear, why does HCG keep resurfacing? Part of the answer is the psychology of rapid results. A patient on 500 calories a day will see the scale drop quickly, and that early win is powerfully reinforcing — it feels like proof that the program “works,” even though the same loss would occur without the injection. The promise of losing weight without hunger and without exercise is, understandably, attractive.

The diet also persists for commercial reasons. Repackaging HCG as drops, sprays, and pellets has kept it inexpensive to produce and easy to market, and the “natural hormone” framing lends it a veneer of legitimacy. None of this changes the underlying science. For a provider, the value of understanding HCG is not in offering it but in being able to recognize the appeal, name it accurately, and redirect the patient toward approaches that are actually supported — including FDA-approved weight-loss medications and modern GLP-1 therapies such as semaglutide.

Responsible framing: what to tell patients

When a patient asks about HCG, the goal is to be honest without being dismissive. The patient is usually motivated and frustrated, and a flat “that's a scam” tends to shut down the conversation rather than help. A more useful approach is to validate the motivation, explain plainly that the weight loss on an HCG program comes from the extreme diet rather than the hormone, and walk through why that distinction matters for their safety and their long-term success.

From there, the conversation can move to what the evidence does support. Obesity is best understood as a chronic, relapsing medical disease, not a failure of willpower, and durable management rarely comes from a three-week crash protocol. The honest provider message is twofold: HCG is not an approved or evidence-supported weight-loss treatment, and the 500-calorie diet attached to it carries real risk. Patients deserve to hear both, alongside an offer of legitimate alternatives — structured nutrition, approved pharmacotherapy where appropriate, and ongoing follow-up — rather than being left to source unregulated drops online.

Provider training and clinical context

For clinicians, the practical skill is not learning to administer HCG — it is learning to place it correctly within the evidence so they can counsel patients well and build a weight-management practice that stands up to scrutiny. That means being fluent in the distinction between FDA-approved, off-label, and unproven options; understanding the genuine science of obesity and the metabolic toolkit that actually moves outcomes; and being able to explain, with empathy and accuracy, why a long-popular protocol does not deliver what it claims.

Empire's curriculum is built around exactly that kind of evidence-honest judgment, connecting topics like HCG to the broader science covered in medical weight loss and to dedicated medical weight loss training for providers who want to counsel patients responsibly and offer therapies that are supported by the data.